Skip to content

Hasnain Faheem

Reporting owner on Forms 3, 4 and 5, CIK 1352620.

Hasnain Faheem reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-11-09.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ASPE · Aspen Neuroscience, Inc.CIK 2124080director, officer (Executive Chair)32026-11-09

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ASPE · Aspen Neuroscience, Inc.Common Stock2026-11-05A granted+321,672$0348,330Form 4
ASPE · Aspen Neuroscience, Inc.Common Stock, holding 36,349Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+14,91314,913Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+14,31614,316Form 4
Aspen Neuroscience, Inc. Common Stock2026-11-02C converted+7,1207,120Form 4
Aspen Neuroscience, Inc. Common Stock, holding 26,658Form 4
Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative2026-11-02C converted-14,9130Form 4
Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative2026-11-02C converted-14,3160Form 4
Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative2026-11-02C converted-7,1200Form 4
Aspen Neuroscience, Inc. Common Stock, holding 26,658Form 3
Aspen Neuroscience, Inc. Series A-1 Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series A-2 Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Series C Convertible Preferred Stock, derivative, holding Form 3
Aspen Neuroscience, Inc. Stock Option (Right to Buy), derivative, holding Form 3
Aspen Neuroscience, Inc. Stock Option (Right to Buy), derivative, holding Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001193125-26-453834 Aspen Neuroscience, Inc.2026-11-09
Form 4 0001193125-26-444126 Aspen Neuroscience, Inc.2026-11-02
Form 3 0001193125-26-439140 Aspen Neuroscience, Inc.2026-10-29